“…Interestingly, fibril fragmentation, which leads to the formation of shorter fibril seeds, is demonstrated as a vital step for the amplification of protein aggregates and the spreading of prion seeds. − This may accelerate the transmission of pathological inclusions into various regions of the brain . However, under normal conditions, protein homeostasis is tightly regulated by protein folding quality control machinery, which maintains the integrity of the proteome and limits the accumulation of protein aggregates. , Hence, fragmentation can be considered as an inherent biological property of amyloid fibrils, which is modulated by numerous factors, including thermal motion, shear forces, mechanical stress, and catalytic activity of molecular chaperones in cells. − For example, fibril disassembly by the human heat shock protein 70 (HSP 70) family promotes the disaggregation of amyloids (such as α-Syn and Tau) into potent species with strong seeding ability and prion-like behavior. − Remarkably, a growing body of evidence suggests that biological attributes of amyloid fibrils can be regulated by the size of the fibrils, which is governed by the magnitude of the fragmentation events to a greater extent. ,, In this context, extensive research has been conducted to understand the correlation between the fragmentation of amyloid fibrils and their cytotoxic potential. − However, the interplay between the heterogeneity of α-Syn fibril size and the mechanism of seed size-dependent secondary nucleation pathways involved in the prion-like transmission of pathological conformers is elusive. Here, we hypothesize that apart from biological and pathological features, the heterogeneity and nanoscale differences in fibril size may regulate the progression of α-Syn pathology by dictating distinct secondary nucleation mechanisms associated with fibril amplification pathways.…”